In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

22:28 EDT 29th August 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,000+

Monday 25th August 2014

The 13th Annual BIO Investor Forum to Host Over 100 Presenting Companies

Presentations will feature biotech companies poised to join the growth “watch list” in 2015 The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the 13th Annual BIO Investor Forum. The event is an inter

Castle Biosciences brings in $11.8mm through late-stage venture round

Molecular diagnostics company Castle Biosciences Inc. raised $11.8mm through a late-stage financing round from new investor HealthQuest Capital (which takes a board seat) and returning backers Mountain Group Capital and affiliates, Longfellow Venture...

Oxford Finance provides diaDexus with $15mm loan

Cardiovascular diagnostics firm diaDexus Inc. entered into a $15mm senior secured term loan agreement with Oxford Finance.

HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia

β-Thalassaemia major (β-TM) is an inherited haemoglobinopathy caused by a quantitative defect in the synthesis of β-globin chains of haemoglobin, leading to the accumulation of free α-globin chains that form toxic aggregates. Despite extensive kn...

Shady Grove Fertility Opens Full Service Treatment Center in Philadelphia

The nation's most progressive fertility center opens 18th location. Bala Cynwyd, PA (PRWEB) August 25, 2014 Shady Grove Fertility is pleased to announce the expansion of our Bala Cynwyd office to five days a week, beginning September 8, 2014. At the Bala Cynwyd office, patients will have the opportunity to see Dr. Isaac E. Sasson and Dr. Sunita Kulshrestha, who are board certified in reproduc...

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates MINNEAPOLIS - Aug. 25, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P, for indicated patients with heart failure or atrioventricular (AV) block. The Viva CRT-P...

Dako Sponsors Largest Histology Congress for 34th Year in a Row

GLOSTRUP, Denmark, August 25, 2014.Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, is a sponsor of this year's National Society for Histotechnology (NSH) Symposium. The 2014 annual meeting for NSH members is being held August 22-27 at the Austin Convention Center in Austin, Texas, where the company will demonstrate a wide range of its...

Cancer Genetics completes acquisition of BioServe India

Cancer Genetics (CGI), a Rutherford, N.J.-based, DNA-based cancer diagnostics provider, has completed the acquisition of BioServe Biotechnologies, a premier genomics services provider serving the research and clinical markets in India.

Johnson & Johnson: High Profitability, Trading Below Fair Value

By Jonathan Weber:Johnson & Johnson (NYSE:JNJ) is one of the biggest healthcare companies in the world, with revenues of $74 billion and earnings of $15.6 billion in the last twelve months. Right now the company has a market capitalization of $291 billion.The company operates in three divisions:- pharmaceutical (40% of sales in 2013)- medical devices and diagnostics (40% of sales in 2013)- con...

Study Results Using OncoE6TM Oral and Cervical Tests

FREMONT, Calif., Aug. 25, 2014 /PRNewswire-iReach/ -- Arbor Vita Corporation, a privately held company, announced today results presented at the 29th International Papillomavirus (IPV) Conference based on the groundbreaking OncoE6TM proteomic-based diagnostics platform applied to diverse clinical settings.  Presentations were given by Charite University Hospital in Berlin, Catholic Hospital B...

Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody for immunotherapy research

PLEASANTON, Calif., Aug. 25, 2014 /PRNewswire/ -- Spring Bioscience (Spring), a member of the Roche Group, today announced the launch of its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody1. This new PD-L1 clone was developed for Roche/Genentech's anti-PD-L1 (MPDL3280A) immunotherapy development program and included in research of various tumor types. As pharmaceutical c...

Agilent Technologies and Shimadzu Enable Control of Each Other’s GC Instruments in Their Respective Chromatographic Data Systems

Agilent has released drivers for Shimadzu GC-2010, GC-2010 Plus and GC-2014 integrating to Agilent’s OpenLAB CDS, and Shimadzu has released drivers to control Agilent 6890, 6850, 7820 and 7890 GC instruments in Shimadzu’s LabSolutions. (PRWEB) August 25, 2014 Agilent Technologies, Inc. and Shimadzu Corp. today announced the release of GC instrument control for their respective Chromatography...

Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay

PLEASANTON, Calif., Aug. 25, 2014 /PRNewswire/ -- Spring Bioscience (Spring), a member of the Roche Group, today announced the launch of its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody1. This new PD-L1 clone was developed for Roche/Genentech's anti-PD-L1 (MPDL3280A) immunotherapy development program. The SP142 antibody is a component of the clinical trial assay de...

Abbott Commences Tender Offer for All Outstanding Ordinary Shares and American Depositary Shares of CFR Pharmaceuticals S.A.

ABBOTT PARK, Ill., Aug. 25, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation ("ALH"), has commenced a tender offer (the "U.S. Offer"), in which it is offering to purchase (i) from U.S. holders only, up to 100 percent of the outstanding ordinary, nominative, no par value shares (th...

Janssen Affiliate Cilag GmbH International Acquires Covagen AG

ZUG, Switzerland, Aug. 25, 2014 /PRNewswire/ -- Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform.  The opportunity was identified...

Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion™ BLA

ENGLEWOOD, Colo., Aug. 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today is issuing this response to the most commonly asked questions in regards to the STEP study and clarify its plan for moving forward with Ampion™ for osteoarthritis of the knee. Letter to Ampio Shareholders from Michael Macaluso, Chairman & CEO and David Bar-Or, MD, Chief Scientif...

Janssen Diagnostics Expands Research Portfolio to Include Next-Generation Sequencing

RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Diagnostics, LLC today announced the addition of next-generation sequencing (NGS) to the portfolio of services it provides pharmaceutical and academic researchers. With this announcement, Janssen Diagnostics continues to drive innovative solutions for its lab services customers by expanding its lab services offering in rare cell detection b...

Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay.

SEATTLE, Aug. 25, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ:  TROV), a developer of cell-free molecular diagnostics, announced today that results from two independent clinical studies were presented at the 29th International Papillomavirus (IPV) Conference. Results from both pilot studies consistently demonstrated that the Company's urine-based assay for the detection of high-risk HPV...

FDAnews Special Subscription Offer for Devices & Diagnostics Letter

For more than 40 years, Devices & Diagnostics Letter has been a must-read for industry leaders eager to stay in compliance with the FDA.With 50 issues a year, readers can be confident that they'll stay abreast of the latest FDA regulations because each bi-weekly issue brings the latest regulatory news. Falls Church, VA (PRWEB) August 25, 2014 Subscribe to Devices & Diagnostics Letter...

Molecular Diagnostics Equipment Industry 2019 Forecasts for Global and China Markets

DALLAS, August 25, 2014 /PRNewswire/ -- DeepResearchReports.com offers 2014 Research Report on Global and China Molecular Diagnostics Equipment Industry, a 231 pages market intelligence premium study published in August 2014. This research offers 16 company profiles along with 180+ data tables and figures to support the business intelligence provided for global and Chinese markets of molecular di...

Potential of the North American Market for PCR Technologies

MUMBAI, August 25, 2014 /PRNewswire/ -- During the past three decades since its invention, PCR has evolved to become one of the fundamental technology platforms in life sciences sector. The application segments of this platform are still expanding, driven by the expiry of key PCR patents. The demand for fast, accurate, and affordable diagnosis tests in healthcare segment has been another key driv...

Nipro Diagnostics, Inc. Announces FDA Clearance of its Newest Blood Glucose Monitoring Systems, TRUE METRIX and TRUE METRIX PRO, and Expansion of Manufacturing in the USA

Nipro Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared its TRUE METRIX™ Self-Monitoring blood glucose system and the TRUE METRIX™ PRO Professional Monitoring blood glucose system. As the diabetes store-brand leader, and largest U.S. manufacturer of diabetes products for the store brand market, Nip...

Sunday 24th August 2014

Fexofenadine HCl Industry for Global and Chinese Markets Forecast to 2019 Now Available at LifeScienceIndustryResearch.com

LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Fexofenadine HCl Industry, 2009-2019” to its store. Inquire before buying this report at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=9591. Dallas, TX (PRWEB) August 24, 2014 This is a professional and in-depth market survey on Global and Chinese Fexofenadine HCl indus...

Roche and InterMune Reach Definitive Merger Agreement

BASEL, Switzerland, Aug. 24, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc. (NASDAQ: ITMN) today announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of $74.00 per share in an all-cash transaction.  This corresponds to a total transaction value of $8.3 billion on a fully diluted basis.  This offer...

Friday 22nd August 2014

Pharmaceutical Packaging Market to see 6.7% CAGR : 2013-2018 Worldwide Forecasts

DALLAS, August 23, 2014 /PRNewswire/ -- The report titled "Pharmaceutical Packaging Market by Packaging Type (Plastic bottles, Blister packs, Caps & Closures, Ampoules, Vials and Others) Raw Material (Plastics, Paper & Paperboard, Glass, Aluminum foils), and Drug Delivery Type - Global Trends & Forecast to 2018" of 424 pages is now available with LifeScienceIndustryResearch.com. The p...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks